510(k) K033915
K033915 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "MODIFICATION TO SERAQUEST EB VCA IGG". The FDA issued a decision of Substantially Equivalent on January 16, 2004. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Quest Intl., Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 16, 2004
- Date Received
- December 18, 2003
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Epstein-Barr Virus, Other
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type